Decreased exhaled nitric oxide in sickle cell disease: Relationship with chronic lung involvement

American Journal of Hematology

Volumn 72, Issue 3, 2003, Pages 177-184

  Girgis, Reda E ^a,b   Qureshi, Mohammed A ^a   Abrams, Judith ^a   Swerdlow, Paul ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute chest syndrome; Airway nitric oxide; Chronic sickle cell lung disease; Dyspnea; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPNEA; EXHALATION; EXPIRATORY FLOW RATE; FEMALE; HUMAN; LUNG FUNCTION; LUNG VASOCONSTRICTION; MALE; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; VITAL CAPACITY;

ADULT; ANEMIA, SICKLE CELL; BREATH TESTS; CHEMILUMINESCENT MEASUREMENTS; CHRONIC DISEASE; DYSPNEA; FEMALE; HEMOGLOBINS; HUMANS; HYDROXYUREA; LUNG DISEASES; MALE; NITRIC OXIDE;

EID: 0037371369     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10284     Document Type: Article

References (59)

1. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994;330(23):1639-1644.
2. Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 1997;129(3):288-293.
3. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997;337(22):1584-1590.
4. Hammerman SI, Kourembanas S, Conca TJ, Tucci M, Brauer M, Farber HW. Endothelin-1 production during the acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 1997;156(1):280-285.
5. Belhassen L, Pelle G, Sediame S, Bachir D, Carville C, Bucherer C, Lacombe C, Galacteros F, Adnot S. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 2001;97(6):1584-1589.
6. Stuart MJ, Setty BN. Acute chest syndrome of sickle cell disease: new light on an old problem. Curr Opin Hematol 2001;8(2):111-122.
7. Aldrich TK, Dhuper SK, Patwa NS, Makolo E, Suzuka SM, Najeebi SA, et al. Pulmonary entrapment of sickle cells: the role of regional alveolar hypoxia. J Appl Physiol 1996;80(2):531-539.
8. Weil JV, Castro O, Malik AB, Rodgers G, Bonds DR, Jacobs TP. NHLBI Workshop Summary. Pathogenesis of lung disease in sickle hemoglobinopathies. Am Rev Respir Dis 1993;148(1):249-256.
9. Minter KR, Gladwin MT. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. Am J Respir Crit Care Med 2001;164(11):2016-2019.
10. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 1988;67(1):66-76.
11. Sutton LL, Castro O, Cross DJ, Spencer JE, Lewis JF. Pulmonary hypertension in sickle cell disease. Am J Cardiol 1994;74(6):626-628.
12. Hammerman SI, Klings ES, Hendra KP, Upchurch GR Jr, Rishikof DC, Loscalzo J, Farber HW. Endothelial cell nitric oxide production in acute chest syndrome. Am J Physiol 1999;277(4 Pt 2):H1579-H1592.
13. Gladwin MT, Schechter AN. Nitric oxide therapy in sickle cell disease. Semin Hematol 2001;38(4):333-342.
14. Space SL, Lane PA, Pickett CK, Weil JV. Nitric oxide attenuates normal and sickle red blood cell adherence to pulmonary endothelium. Am J Hematol 2000;63(4):200-204.
15. Dweik RA, Laskowski D, Abu-Soud HM, Kaneko F, Hutte R, Stuehr DJ, Erzurum SC. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 1998;101(3):660-666.
16. Ide H, Nakano H, Ogasa T, Osanai S, Kikuchi K, Iwamoto J. Regulation of pulmonary circulation by alveolar oxygen tension via airway nitric oxide. J Appl Physiol 1999;87(5):1629-1636.
17. Clini E, Cremona G, Campana M, Scotti C, Pagani M, Bianchi L, Giordano A, Ambrosino N. Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Respir Crit Care Med 2000;162(2 Pt 1):446-450.
18. Kharitonov SA, Cailes JB, Black CM, du Bois RM, Barnes PJ. Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52(12):1051-1055.
19. Kaneko FT, Arroliga AC, Dweik RA, Comhair SA, Laskowski D, Oppedisano R, Thomassen MJ, Erzurum SC. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am J Respir Crit Care Med 1998;158(3):917-923.
20. Vichinsky EP, Neumayr LD, Earles AN, Williams R, Lennette ET, Dean D, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med 2000;342(25):1855-1865.
21. American Thoracic Society. Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 1999;160(6):2104-2117.
22. th edition. Boston: WCB/McGraw-Hill; 1996.
23. Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-836.
24. Gladwin MT, Shelhamer JH, Ognibene FP, Pease-Fye ME, Nichols JS, Link B, et al. Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease. Br J Haematol 2002;116(2):436-444.
25. Sullivan KJ, Kissoon N, Duckworth LJ, Sandler E, Freeman B, Bayne E, Sylvester JE, Lima JJ. Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am J Respir Crit Care Med 2001;164(12):2186-2190.
26. 2 in humans: effect of dynamically changing flow rate. J Appl Physiol 1998;85(2):642-652.
27. Sartori C, Lepori M, Busch T, Duplain H, Hildebrandt W, Bartsch P. Nicod P, Falke KJ, Scherrer U. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med 1999;160(3):879-882.
28. Dimberger E, Lucan H, Eichler HG, Kastner J, Pernerstorfer T, Jilma B. Effects of nitroglycerin and sodium nitroprusside on endexpiratory concentrations of nitric oxide in healthy humans. Life Sci 1998:62(8):L103-L108.
29. Pawloski JR, Hess DT, Stamler JS. Export by red blood cells of nitric oxide bioactivity. Nature 2001;409(6820):622-626.
30. Pietropaoli AP, Perillo IB, Torres A, Perkins PT, Frasier LM, Utell MJ, et al. Simultaneous measurement of nitric oxide production by conducting and alveolar airways of humans. J Appl Physiol 1999; 87(4):1532-1542.
31. Gugnani MK, Swerdlow P, Girgis RE. Exhaled nitric oxide in sickle cell disease (abstract). Am J Resp Crit Care Med 2000;161:A421.
32. Silkoff PE, Sylvester JT, Zamel N, Permutt S. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000;161(4 Pt 1):1218-1228.
33. Tsoukias NM, George SC. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998;85(2):653-666.
34. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr 2001;138(2):188-192.
35. Ho LP, Wood FT, Robson A, Innes JA, Greening AP. The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre. Eur Respir J 2000;15(6):1009-1013.
36. Enwonwu CO, Xu XX, Turner E. Nitrogen metabolism in sickle cell anemia: free amino acids in plasma and urine. Am J Med Sci 1990;300(6):366-371.
37. Morris CR. Kuypers FA, Larkin S, Vichinsky EP, Styles LA. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J Pediatr Hematol Oncol 2000;22(6):515-520.
38. Morris CR, Kuypers FA, Larkin S, Sweeters N, Simon J, Vichinsky EP, Styles LA. Arginine therapy: a novel strategy to induce nitric oxide production in sickle cell disease. Br J Haematol 2000;111(2): 498-500.
39. Stuart MJ, Setty BN. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Blood 1999;94(5):1555-1560.
40. Rees DC, Cervi P, Grimwade D, O'Driscoll A, Hamilton M, Parker NE, et al. The metabolites of nitric oxide in sickle-cell disease. Br J Haematol 1995;91(4):834-837.
41. Lopez BL, Davis-Moon L, Ballas SK, Ma XL. Sequential nitric oxide measurements during the emergency department treatment of acute vasoocclusive sickle cell crisis. Am J Hematol 2000;64(1):15-19.
42. Asian M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, et al. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci U S A 2001;98(26): 15215-15220.
43. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric oxidemediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol 2000;278(6):H1799-H1806.
44. Nath KA, Shah V, Haggard JJ, Croatt AJ, Smith LA, Hebbel RP, Katusic ZS. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol 2000;279(6):R1949-R1955.
45. Wechsler ME, Grasemann H, Deykin A, Silverman EK, Yandava CN, Israel E, Wand M, Drazen JM. Exhaled nitric oxide in patients with asthma: association with NOS 1 genotype. Am J Respir Crit Care Med 2000;162(6):2043-2047.
46. Yates DH, Kharitonov SA, Thomas PS, Barnes PJ. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996;154(1):247-250.
47. De Sanctis GT, Mehta S, Kobzik L, Yandava C, Jiao A, Huang PL, Drazen JM. Contribution of type I NOS to expired gas NO and bronchial responsiveness in mice. Am J Physiol 1997;273(4 Pt 1):L883-L888.
48. Klings ES, Christman BW, McClung J, Stucchi AF, McMahon L, Brauer M, Farber HW. Increased F2 isoprostanes in the acute chest syndrome of sickle cell disease as a marker of oxidative stress. Am J Respir Crit Care Med 2001;164(7):1248-1252.
49. Asian M, Thornley-Brown D, Freeman BA. Reactive species in sickle cell disease. Ann NY Acad Sci 2000;899:375-391.
50. Sultana C, Shen Y, Rattan V, Johnson C, Kalra VK. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes. Blood 1998;92(10):3924-3935.
51. Schacter L, Warth JA, Gordon EM, Prasad A, Klein BL. Altered amount and activity of superoxide dismutase in sickle cell anemia. FASEB J 1988;2(3):237-243.
52. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982;70(6):1253-1259.
53. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL. Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci U S A 1996;93(13):6770-6774.
54. Lancaster JR Jr. Reaping of nitric oxide by sickle cell disease. Proc Natl Acad Sci U S A 2002;99(2):552-553.
55. Busch T, Bartsch P, Pappert D, Grunig E, Hildebrandt W, Elser H, Falke KJ, Swenson ER. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med 2001;163(2):368-373.
56. Blitzer ML, Loh E, Roddy MA, Stamler JS, Creager MA. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol 1996;28(3):591-596.
57. Gladwin MT, Schechter AN, Shelhamer JH, Ognibene FP. The acute chest syndrome in sickle cell disease. Possible role of nitric oxide in its pathophysiology and treatment. Am J Respir Crit Care Med 1999;159(5 Pt 1):1368-1376.
58. Deem S, Swenson ER, Alberts MK, Hedges RG, Bishop MJ. Red-blood-cell augmentation of hypoxic pulmonary vasoconstriction: hematocrit dependence and the importance of nitric oxide. Am J Respir Crit Care Med 1998;157(4 Pt 1): 1181-1186.
59. Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95(8):2068-2074.